Status | Study |
Completed |
Study Name: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Condition: Adult Malignant Fibrous Histiocytoma of Bone Desmoid Tumor Date: 2007-05-16 Interventions: Drug: sunitinib malate |
Active, not recruiting |
Study Name: Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Condition: Sarcoma Date: 2007-01-17 Interventions: Radiation: radiotherapy radiotherapy as adjuvant treatment for adults with soft tissue sarcoma extremiti |
Active, not recruiting |
Study Name: Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Condition: Ovarian Cancer Sarcoma Small Intestine Cancer Date: 2006-12-11 Interventions: Drug: brostallicin Drug: doxorubicin hydro |
Active, not recruiting |
Study Name: Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma Condition: Sarcoma Date: 2006-09-19 Interventions: Biological: dactinomycin Drug: carboplatin |
Active, not recruiting |
Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Condition: Adult Malignant Mesenchymoma Adult Rhabdomyosarcoma Date: 2006-07-19 Interventions: Drug: Irinotecan Hydrochloride |
Active, not recruiting |
Study Name: High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma Condition: Sarcoma Date: 2006-07-19 Interventions: Biological: dactinomycin |
Completed |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition: Adult Alveolar Soft-part Sarcoma Adult Angiosarcoma Adult Date: 2006-06-28 Interventions: Drug: doxorubicin hydrochloride |
Completed |
Study Name: Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Condition: Life Threatening Diseases Date: 2005-09-09 Interventions: Drug: Imatinib mesylate |
Completed |
Study Name: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Condition: Adult Alveolar Soft-part Sarcoma Adult Angiosarcoma Adult Date: 2005-06-02 Interventions: Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa |
Active, not recruiting |
Study Name: Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma Condition: Sarcoma Date: 2004-02-10 Interventions: Biological: filgrastim Drug: carboplatin |